SE
Shimon Eckhouse Ph.D.
Co-Founder & Chairman of the Board
ChairmanFounder
born 1945comp · ₪49,000
LOADING SNAPSHOT
Fetching the books…
Epitomee Medical Ltd develops and commercializes ingestible therapeutic devices in Israel. The company offers capsules for the treatment of overweight and obesity.
For commercial pharma: watch patent cliffs and competition. For pre-revenue biotech: cash runway and trial readouts.
Mixed signals — interesting but with caveats. Worth a deeper look before committing capital.
| Period | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2021-12-31 | — | — | — | — | — |
| 2022-12-31 | — | — | ₪-11.07M | ₪-15.39M | — |
| 2023-12-31 | ₪10.00M | — | ₪416.00K | ₪-5.68M | -56.8% |
| 2024-12-31 | — | — | ₪-8.98M | ₪-1.46M | — |
| 2025-12-31 | ₪213.00K | ₪-654.00K | ₪-9.53M | ₪-8.61M | -4043.2% |
Epitomee Medical Ltd develops and commercializes ingestible therapeutic devices in Israel. The company offers capsules for the treatment of overweight and obesity. It also focuses on developing biologic drug delivery solutions. Epitomee Medical Ltd was incorporated in 2005 and is based in Caesarea, Israel.